Phase III Trial Of Irofulven Vs. 5-Fluorouracil In Patients With Gemcitabine-Refractory Advanced Pancreatic Adenocarcinoma.
Latest Information Update: 11 Sep 2009
At a glance
- Drugs Irofulven (Primary) ; Fluorouracil
- Indications Ductal carcinoma; Pancreatic cancer
- Focus Registrational; Therapeutic Use
- 09 Sep 2009 Additional lead trial centre (Eisai Inc.) identified as reported by ClinicalTrials.gov.
- 03 Sep 2005 New trial record.